chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my 2nd dose of Pfizer Covid vaccine at 10am on Wednesday, Aug 25, 2021. Approximately 12 hours later at 10pm, I developed the standard side effects of tiredness, chills, and body aches. I took  extra strength Tylenol. Those symptoms lasted about 24 hours (thru the night and all day the next day, Aug 26, 2021, ending around 10pm). Other than tiredness, I felt normal by Friday, Aug 27, 2021. That changed though when I awoke around 8am on Saturday morning, Aug 28, 2021, to a weird sensation of being pricked by pins and needles all over my body and skin crawling. I felt tingling in my head and as if my hair was standing on end. I also felt as if I was burning up with a high fever, but I had a normal temperature. I called the pharmacy where I got the vaccine, but was told they had never heard of those side effects. I called the local clinic that I belong to and was told they had never heard of those side effects either. They told me I could come in and be evaluated by a doctor. I proceeded to go into the clinic and see a doctor on call. She was not familiar with the side effects, but said it did sound like I was having an adverse reaction to the vaccine. She told me to go home and keep Benadryl in my system and take Tylenol as needed. That is what I proceeded to do and the symptoms were managable as long as I stayed on Benadryl (even though Benadryl did not take the symptoms away 100%). I continued in this cycle and with the side effect and Benadryl until Wednesday morning, Sept 1,2021, when i awoke and had my 1st day of no symptoms and was able to stop the Benadryl.
Arm pain, headache, chills, muscular aches R-arm, adverse affects in both vaccines, R arm.
Daily heartburn/acid reflux started approximately 5 days after my first shot.  This continued daily for 3 weeks until I started taking medication to stop it.  I never had heartburn in the past.
No additional AE's and no PQC's were reported.; The nurse stated that improperly stored vaccines were administered to patients.; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported.   On 06-APR-2022, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live Albumin status rHA (recombinant Human albumin) (PROQUAD) lot# U022724, expiration date reported as 16-JAN-2023, use as directed to prevent measles, mumps, rubella and varicella infection (prophylaxis) (strength, dose, route and frequency were not reported).   The temperature excursion was of 7.5 Fahrenheit degrees (°F), during 15 minutes. A previous temperature excursion was not reported. No additional adverse event and no PQC's were reported.
Child had hour long nose bleed at school the next day. Fully recovered without need for intervention.
Moderate pain at the injection site lasted ~36 hours after shot. Six days after vaccine was given, I experienced an enlarged lymph node on the left side base of my neck. The lymph node was about the size of a dime, firm, and tender to the touch. Minimal armpit pain was experienced (similar to an ingrown hair), except there wasn't an ingrown hair. On the 7th day, about  15 hours after noticing the enlarged lymph node, swelling and tenderness has reduced, but has not disappeared completely.
Patient received 6mg old immunizations Pentacel #3, Prevnar #3 Rotavirus pneumo #3 One day after immunizations developed diarrhea and fever. 6 days later developed blood diarrhea. Seen in ED and discharged.
4/24 midnight: muscle pain and joint pain 4/26 recovered from the pain 4/25 Started to have rashes on the face, side of nose then inside the nose, then around the eyes 5/2 Swollen eyes got worse each morning after 5/2 5/4 Went to urgent care and later ER, because of red eyes, shingles liked symptoms around both eyes (eye lids) and numbness on the left side of the face.  Got prescription for valacyclovir and ganciclovir ophthalmic gel.  5/5 Eyes are still swollen but not worse compare to the day before. Some joint pain still persists (left hand)
severe stomach pain; spasms in stomach; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Apr2021 at 12:45 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Medical history included mTBI - post concussion syndrome. Concomitant medications included paracetamol (TYLENOL) for unspecified indication from one day before and day of (as reported). The patient previously took cefalexin (CEPHALEXIN) for unspecified indication on unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, approximately 24 hours after the vaccine, the patient experienced very severe stomach pain and spasms in stomach and took 4 baths, switched positions constantly as it was hurting so bad. This lasted about 9 or 10 hours. The pain was very severe in the middle of stomach and was hurting to touch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events severe stomach pain and spasms in stomach were recovered on 04Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021384951 same reporter/event/drug, different patient
19 hours: left eye went dark, left leg muscle contraction, 21 hrs: major muscles seized for 15 minutes(felt like they were tearing from bone), Fever for next 12 hours
This spontaneous report as received from a registered nurse (who was also a supervisor) refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.    On 30-JAN-2017, the patient was vaccinated with an expired dose of ZOSTAVAX 19400 plaque-forming unit (PFU), lot # L027321 with expiration date 21-OCT-2016 (dose and route of administration were not reported). There was no adverse effect reported. Additional information has been requested.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details: NO EMS needed, pt felt on her head
Pt is a 15 months 19 days old female who presents for injection site reaction on her (L) thigh after a DTAP injection Weds. She also felt feverish. 3 d after shot some hive type lesions developed on her (L) LE but did not involve other parts of body. She had previous DTAP shots without any noted reactions. Reck of rash. This seemed to start since her dtap and she has had some urticarial sxs also. Mom brings in pictures on her phone. No fever. Eating ok and active but fussy. They have been using some BENADRYL. Follow up if problem worsens or does not resolve completely.
Pt developed 2x2cm scar effect on right arm where flu vaccine was injected. (OMIC) Per 60 day follow up: Pt has residual "scar effect" lesion on right arm where vaccine was given.
Contracted COVID 2 months after second shot (second dose administered on 05/17/21) and passed away after hospitalization.
Scrapes on left leg; This spontaneous case was reported by a consumer and describes the occurrence of SKIN ABRASION (Scrapes on left leg) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced SKIN ABRASION (Scrapes on left leg). At the time of the report, SKIN ABRASION (Scrapes on left leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
I felt very woozy when I left vaccine site & so I went home & the next day I went swimming & I passed out in the swimming pool I noticed my heart was beating faster I have since been diagnosed with Tachycardia.
A multitude of arrhythmias, including A Fib, supraventricular ectopy, multiple PVCs, PACs.
right arm (injection site) and shoulder sore and painful  to raise above head, migraine lasting 12hr, stiffness and pain  in knee and hip joints, sore throat. All symptoms resolved within 2 days
patient came in this morning (monday) with a red band across her lower bicep that is warm and swollen. started yesterday (day after shot). recommended tylenol and ice
Facility MD obtained consent for patient's mother. Patient received vaccine based upon facility list provided.  When entering information, it was noted that patient is currently age 11.  Facility MD was notified that patient received vaccine and is currently outside of the age range for approved age.  Patient's mother was notified. Mother and MD have no concerns at this time and if patient does not display any side effects, they would like patient to potentially receive the second dose.
Information has been received from e registered nurse concerning a female in her 50's clinically compromised with no drug allergies who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5 ml) (intramuscularly).  There was no concomitant medication.  Subsequently the patient experienced puffy swelling from under ears to and including hands.  Ibuprofen (ADVIL) was given for the redness and swelling.  The patient recovered.  It was noted that the patient had no history of reactions to any other vaccines and was not diabetic.  It was also noted that the patient was clinically compromised but that pneumococcal 23v polysaccharide vaccine was given because the benefits outweighed the risks.  It was also reported that another patient had the same experienced.  Additional information has been requested.
loss of hair alot; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (loss of hair alot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (loss of hair alot). At the time of the report, ALOPECIA (loss of hair alot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment medications information was not provided.
Rec'd MCV4 at 1:40 PM 3/22/07. Began to feel dizzy at 3:30 PM 3/22/07. Tired, H/A, dizzy for 4 days. Dizzy only (3/26/07) today. Has remained afebrile since vaccinated with MCV4.
Three weeks after the vaccine, I felt a lump under my left arm. There was no pain. I felt it and went to get an Ultrasound and Mammogram - normal results.  No treatment.
same day- mild arm pain/Next day- moderate arm pain; severe headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Apr2021 11:15 (Lot number: Ew0150) at the age of 30 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: cherries" (unspecified if ongoing), notes: Known allergies: Ceclor, cherries. Concomitant medication(s) included: MINOCYCLINE. Past drug history included: Ceclor, reaction(s): "Known allergies: Ceclor", notes: Known allergies: Ceclor, cherries. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 04Apr2021, outcome "recovered" (06Apr2021), described as "same day- mild arm pain/Next day- moderate arm pain"; HEADACHE (non-serious) with onset 04Apr2021, outcome "recovered" (06Apr2021), described as "severe headache". Therapeutic measures were not taken as a result of pain in extremity, headache.  Addition information: Patient had no other vaccine in four weeks. Patient had no COVID prior vaccination and had not tested COVID post vaccination.  No follow-up attempts are possible. No further information is expected.
Throat tightness. Hx allergies, lung sounds clear, stridor over trachea, Transport to PRH-Dover ED. Transport to ED w/ no incident.
This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported that a female patient of an unspecified age received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: Unknown), via an unspecified route of administration as dose 2, single on an unspecified date for covid-19 immunisation. Medical history included ongoing rheumatoid arthritis (diagnosed and receiving an infusion), pneumonia and Covid 19 (she also had Covid and had pneumonia, this was before receiving the vaccine) and ongoing hepatitis B (diagnosed and receiving an infusion) all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Historical vaccine included patient previously took bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: Unknown), via an unspecified route of administration as dose 1, single on an unspecified date for covid-19 immunisation and experienced tingling in her feet and hands. Caller was a consumer, called regarding her sister (patient), who had the first dose of the Pfizer Covid-19 vaccine. After that, she experienced tingling in her feet and hands did not specify right or left. After patient received the second dose, she had been going downhill, not been able to eat, bloating and gone down to 111 pounds on unspecified date in 2021. Patient saw many doctors who can't find anything wrong with her. Patient does not have cancer and has had blood work. Caller was not sure why patient was going downhill, it because of everything going on, plus the vaccine. Caller was concerned about patient (sister). The patient underwent lab tests and procedures which included investigation: unknown and weight decreased: 111 pounds on unspecified date. At the time of this report, the outcome of events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Around the injection site arm was warm; Around the injection site arm was red; Around the injection site arm was tender; Stiff fingers on left hand, and stiffness extended through hand and wrist; Wrist is still tender and painful/ elbow pain; Wrist is hot around stiffness; Cannot close hand all the way; Has lost grip strength; Pain extends from wrist to shoulder and elbow; Swelling in wrist has not gone down and extends to fingers; Radiating pain; This case was reported by a consumer via call center representative and described the occurrence of injection site warmth in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number AA3K4, expiry date 6th December 2021) for prophylaxis.   Previously administered products included Shingles vaccine (received shingles shot on an unknown date).   On 14th October 2019, the patient received the 1st dose of Shingrix. On 15th October 2019, 1 days after receiving Shingrix, the patient experienced injection site warmth, injection site erythema and injection site pain. In October 2019, the patient experienced limbs stiffness, wrist pain, feeling of warmth, mobility decreased, grip strength decreased, shoulder pain, swelling of wrists and radiating pain. On an unknown date, the outcome of the injection site warmth, injection site erythema, injection site pain, wrist pain, feeling of warmth, mobility decreased, grip strength decreased, shoulder pain, swelling of wrists and radiating pain were unknown and the outcome of the limbs stiffness was recovering/resolving.   It was unknown if the reporter considered the injection site warmth, injection site erythema, injection site pain, limbs stiffness, wrist pain, feeling of warmth, mobility decreased, grip strength decreased, shoulder pain, swelling of wrists and radiating pain to be related to Shingrix.  Additional details were reported as follows: The case was reported by patient's husband. The reporter stated that the patient experienced around the injection site arm was warm, red and tender approximately 2 quarters around. The reporter stated that placing palm on arm and feeling warmth on palm. The reporter stated that the patient woke up with stiff fingers on left hand, and stiffness extended through hand and wrist. The reporter stated that the hand pain became progressively painful and worse and wrist was tender and painful and hot around stiffness. The reporter stated that the patient could not close hand all the way and that she had lost grip strength, finger pads are tender to touch, and pain extends from wrist to shoulder and elbow. The reporter stated that the swelling in the patient's wrist has not gone down and extends to fingers including pinky and left wrist was noticeably larger. The patient also had intermittent shooting pain to shoulder as well. This case has been linked with case US2020AMR006218 and US2020AMR006219, reported for same patient.
redness around injection site; Itchiness/ Itchiness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Itchiness/ Itchiness) and INJECTION SITE ERYTHEMA (redness around injection site) in an unknown age, female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.    Co-suspect product included non-company product LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for an unknown indication.    Previously administered products included for an unreported indication: .   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) (unknown route) at an unspecified dose. On 16-Jan-2021, the patient experienced INJECTION SITE PRURITUS (Itchiness/ Itchiness). On 25-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (redness around injection site). On 17-Jan-2021, INJECTION SITE PRURITUS (Itchiness/ Itchiness) outcome was unknown. At the time of the report, INJECTION SITE ERYTHEMA (redness around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Upon in internal review on 21 May 2021, the age was corrected to unknown age.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05May2023 at 16:00 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 58 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing). No known allergies. Concomitant medication(s) included: OMEPRAZOLE, start date: 05Sep2019. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: patient received COVID 19 Treatment (brand: Pfizer) from 10Aug2023 to 15Aug2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Initial case reported in non-scientific literature on 10 November 2009. It contains information for one patient in a cluster of nine patients who experienced adverse events following vaccination with H1N1 vaccine. The other patients' events are captured in case numbers 2009-04868 (one identified patient) and 2009-04870 (seven unidentified patients). A female adolescent patient received H1N1 (manufacturer and lot number not reported) on 04 November 2009 and subsequently experienced shortness of breath, a high fever, hives, and an itchy rash. The patient received the vaccine at school, and the events began within 15 minutes of vaccination. She was transported to the hospital via ambulance, where she was treated and released (specific treatment not reported). No additional information was provided. Documents held by sender: None.
Client is 17 years of age and received the Moderna Vaccine at this time. Clients mother was notified of medication error at this time. This nurse advised that Client will need to wait to get second round of vaccine until after he turns 18. This nurse will follow up with parent with any additional information obtained.
Seizure like activity, dystonia like activity, fever, lethargic, visually not responsive x 4 days.
Soreness at injection site.  Redness at injection site. Swelling under armpit on the same arm as injection.  No medical treatment yet. Just monitoring swelling.
headache, body stiff and tired; headache, body stiff and tired; headache, body stiff and tired; This is a spontaneous report from a contactable pharmacist reported for a patient. A female patient of an unspecified age (patient was not pregnant at the time of vaccination) received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 15Feb2021 (age at vaccination was unknown) as dose number unknown, single for COVID-19 immunization. The patient's medical history was not reported. It was unknown if the patient received any concomitant medications or other medications in two weeks. It was unknown if the patient received any other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 16Feb2021, the patient experienced headache, body stiff and tired. No treatment was received for the adverse events. The outcome of the events was unknown.   Follow-up attempts completed. No further information expected.